Manuscripts

Search by keyword, year, or author name.

Showing 1533 manuscripts.

The effect of lamivudine therapy and M184V on the antiretroviral activity of didanosine

Joseph J. Eron, Ronald J. Bosch, Daniel Bettendorf, Michael P. Bates, Leslie A. Petch, Susan A. Fiscus, Ian Frank. The effect of lamivudine therapy and M184V on the antiretroviral activity of didanosine. Journal of Acquired Immune Deficiency Syndromes. 2007. 45: 249-51.

Year

2007

Journal

Journal of Acquired Immune Deficiency Syndromes

The use of [beta]-D-2,6-diaminopurine dioxolane with or without mycophenolate mofetil in drug-resistant HIV infection

David M. Margolis, Lisa Mukherjee, Courtney V. Fletcher, Evelyn Hogg, Debra M. Ogata-Arakaki, Tianna Petersen, Dave H. Rusin, Ana I. Martinez, John W. Mellors. The use of [beta]-D-2,6-diaminopurine dioxolane with or without mycophenolate mofetil in drug-resistant HIV infection. AIDS. 2007. 21: 2025-32.

Year

2007

Journal

AIDS

Progression of carotid artery intima-media thickening in HIV-infected and uninfected adults

Judith Silverstein Currier, Michelle A. Kendall, W. Keith Henry, Beverly L. Alston-Smith, Francesca J. Torriani, Pablo Tebas, Yanjie Li, Howard N. Hodis. Progression of carotid artery intima-media thickening in HIV-infected and uninfected adults. AIDS. 2007. 21: 1137-45.

Year

2007

Journal

AIDS

Intensification of a triple-nucleoside regimen with tenofovir or efavirenz in HIV-1-infected patients with virological suppression

Roy (Trip) Gulick, Christina M. Lalama, Heather Ribaudo, Cecilia M. Shikuma, Bruce R. Schackman, Jeffrey T. Schouten, Kathleen E. Squires, Susan L. Koletar, Christopher D. Pilcher, Richard C. Reichman, Karin L. Klingman, Daniel R. Kuritzkes. Intensification of a triple-nucleoside regimen with tenofovir or efavirenz in HIV-1-infected patients with virological suppression. AIDS. 2007. 21: 813-23.

Year

2007

Journal

AIDS

Comparison of direct and indirect measurement of LDL-C in HIV-infected individuals: ACTG 5087

Scott Evans, Carl J. Fichtenbaum, Judith A. Aberg. Comparison of direct and indirect measurement of LDL-C in HIV-infected individuals: ACTG 5087. HIV Clinical Trials. 2007. 8: 45-52.

Year

2007

Journal

HIV Clinical Trials

Effect of concomitantly administered rifampin on the pharmacokinetics and safety of atazanavir administered twice daily

Edward P. Acosta, Michelle A. Kendall, John G. Gerber, Beverly L. Alston-Smith, Susan L. Koletar, Andrew R. Zolopa, Sangeeta Agarwala, Michael J. Child, Richard J. Bertz, Lara A. Hosey, David W. Haas. Effect of concomitantly administered rifampin on the pharmacokinetics and safety of atazanavir administered twice daily. Antimicrobial Agents and Chemotherapy. 2007. 51: 3104-10.

Year

2007

Journal

Antimicrobial Agents and Chemotherapy

Selegiline transdermal system (STS) for HIV-associated cognitive impairment: open-label report of ACTG 5090

Scott Evans, Tzu-min Yeh, Ned Sacktor, David B. Clifford, David M. Simpson, Eric N. Miller, Ronald J. Ellis, Victor G. Valcour, Christina M. Marra, Linda L. Millar, Giovanni Schifitto. Selegiline transdermal system (STS) for HIV-associated cognitive impairment: open-label report of ACTG 5090. HIV Clinical Trials. 2007. 8: 437-46.

Year

2007

Journal

HIV Clinical Trials

Integration of atazanavir into an existing liquid chromatography UV method for protease inhibitors: validation and application

Kim Keil, Jill S. Hochreiter, Robin DiFrancesco, Barry Zingman, Richard C. Reichman, Margaret A. Fischl, Barbara Gripshover, Gene D. Morse. Integration of atazanavir into an existing liquid chromatography UV method for protease inhibitors: validation and application. Therapeutic Drug Monitoring. 2007. 29: 103-9.

Year

2007

Journal

Therapeutic Drug Monitoring

Pharmacokinetic interaction between efavirenz and dual protease inhibitors in healthy volunteers

Qing Ma, Alan Forrest, Susan L Rosenkranz, Michael F. Para, Kevin E. Yarasheski, Richard C. Reichman, Gene D. Morse. Pharmacokinetic interaction between efavirenz and dual protease inhibitors in healthy volunteers. Biopharmaceutics & Drug Disposition. 2007. 29: 91-101.

Year

2007

Journal

Biopharmaceutics & Drug Disposition

A truvada hypersensitivity reaction simulating abacavir hypersensitivity

Peter T. Frame, Carl J. Fichtenbaum. A truvada hypersensitivity reaction simulating abacavir hypersensitivity. AIDS. 2007. 21: 2252-3.

Year

2007

Journal

AIDS